The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
about
sameAs
Aspartame: A Safety Evaluation Based on Current Use Levels, Regulations, and Toxicological and Epidemiological StudiesProliferative and non-proliferative lesions of the rat and mouse integument.Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.The use of genetically modified mice in cancer risk assessment: challenges and limitations.Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic ageAn industry perspective on the utility of short-term carcinogenicity testing in transgenic mice in pharmaceutical development.Species and gender differences in the carcinogenic activity of trimethylolpropane triacrylate in rats and miceCritical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.Molecular docking and analysis of survivin delta-ex3 isoform protein.Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.Investigations of clofibrate in alternative carcinogenicity models.Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.Comparative dermal toxicity of dicyclohexylcarbodiimide and diisopropylcarbodiimide in rodents.High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
P2860
Q23901998-57F87B16-CD5D-4CCA-8B33-595982FAF38DQ33880072-1C41E855-2EB2-434F-B42C-0566CBCD64ACQ34590545-61E01B03-D781-4FAE-9B95-4784871EAF63Q35688431-D45BFCC8-10F5-46A6-8027-FB7C9D4F9212Q36070444-4AF9A160-1DD4-453E-9DDE-02D3ABACD08DQ37628343-07C65C88-1364-4478-A961-2CE995588687Q37715831-216BCADC-CAC1-4396-9C74-47C486CF79E0Q37795414-206ED20B-B163-4B14-9817-779EC15F55A6Q41845070-61829E7A-A93B-4059-8533-5C1D7DCE1CEBQ46715037-C35208BB-D7D3-44E3-9071-088630D3F728Q46781510-71BA3B19-551A-443E-BD6A-956D3E623F2FQ46781520-8C41F3CC-E35B-469F-A341-382B67689AE5Q46781523-4DC1A1C3-DFB6-47EB-B969-967F02EBA11FQ46781526-1E33A56E-8F16-43D0-B135-86BF08D360CBQ53207707-068C237F-1A1A-4E1F-BE54-4E6108F1BE82Q53357105-464055A6-E5BF-4AAC-BB53-63A6B2020FF2
P2860
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@ast
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@en
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@nl
type
label
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@ast
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@en
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@nl
prefLabel
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@ast
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@en
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@nl
P2093
P1476
The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model
@en
P2093
J H Mennear
J W Spalding
R W Tennant
S Stasiewicz
W C Eastin
P356
10.1080/019262301753178474
P407
P478
P577
2001-01-01T00:00:00Z